Detalhe da pesquisa
1.
The NK cell granule protein NKG7 regulates cytotoxic granule exocytosis and inflammation.
Nat Immunol
; 21(10): 1205-1218, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32839608
2.
Author Correction: The NK cell granule protein NKG7 regulates cytotoxic granule exocytosis and inflammation.
Nat Immunol
; 25(4): 716, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38360937
3.
CD155 on Tumor Cells Drives Resistance to Immunotherapy by Inducing the Degradation of the Activating Receptor CD226 in CD8+ T Cells.
Immunity
; 53(4): 805-823.e15, 2020 10 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33053330
4.
NMDAR antagonists suppress tumor progression by regulating tumor-associated macrophages.
Proc Natl Acad Sci U S A
; 120(47): e2302126120, 2023 Nov 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37967215
5.
TIGIT and CD96: new checkpoint receptor targets for cancer immunotherapy.
Immunol Rev
; 276(1): 112-120, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28258695
6.
TIGIT immune checkpoint blockade restores CD8+ T-cell immunity against multiple myeloma.
Blood
; 132(16): 1689-1694, 2018 10 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-29986909
7.
The immune checkpoint CD96 defines a distinct lymphocyte phenotype and is highly expressed on tumor-infiltrating T cells.
Immunol Cell Biol
; 97(2): 152-164, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30222899
8.
Poor prognosis of patients with triple-negative breast cancer can be stratified by RANK and RANKL dual expression.
Breast Cancer Res Treat
; 164(1): 57-67, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28417335
9.
Rankl Impairs Lactogenic Differentiation Through Inhibition of the Prolactin/Stat5 Pathway at Midgestation.
Stem Cells
; 34(4): 1027-39, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26695351
10.
RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis.
Nature
; 468(7320): 103-7, 2010 Nov 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-20881963
11.
RANK-ligand (RANKL) expression in young breast cancer patients and during pregnancy.
Breast Cancer Res
; 17: 24, 2015 Feb 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-25849336
12.
RANKL expression in normal and malignant breast tissue responds to progesterone and is up-regulated during the luteal phase.
Breast Cancer Res Treat
; 146(3): 515-23, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25007964
13.
RANK expression as a prognostic and predictive marker in breast cancer.
Breast Cancer Res Treat
; 145(2): 307-15, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24737168
14.
Constitutive activation of RANK disrupts mammary cell fate leading to tumorigenesis.
Stem Cells
; 31(9): 1954-65, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23766243
15.
RANK and RANKL Expression in Tumors of Patients with Early Breast Cancer.
Geburtshilfe Frauenheilkd
; 84(1): 77-85, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38178900
16.
Progestin effects on cell proliferation pathways in the postmenopausal mammary gland.
Breast Cancer Res
; 15(4): R62, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23938070
17.
Inhibition of CD39 unleashes macrophage antibody-dependent cellular phagocytosis against B-cell lymphoma.
Leukemia
; 37(2): 379-387, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36539557
18.
RANKL inhibition combined with tamoxifen treatment increases anti-tumor efficacy and prevents tumor-induced bone destruction in an estrogen receptor-positive breast cancer bone metastasis model.
Breast Cancer Res Treat
; 135(3): 771-80, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22926264
19.
RANK overexpression in transgenic mice with mouse mammary tumor virus promoter-controlled RANK increases proliferation and impairs alveolar differentiation in the mammary epithelia and disrupts lumen formation in cultured epithelial acini.
Mol Cell Biol
; 27(4): 1442-54, 2007 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-17145767
20.
Tumor CD155 Expression Is Associated with Resistance to Anti-PD1 Immunotherapy in Metastatic Melanoma.
Clin Cancer Res
; 26(14): 3671-3681, 2020 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32345648